233 related articles for article (PubMed ID: 23427294)
1. Crizotinib induces PUMA-dependent apoptosis in colon cancer cells.
Zheng X; He K; Zhang L; Yu J
Mol Cancer Ther; 2013 May; 12(5):777-86. PubMed ID: 23427294
[TBL] [Abstract][Full Text] [Related]
2. Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.
Yang S; Zhu Z; Zhang X; Zhang N; Yao Z
Oncotarget; 2017 Jan; 8(4):6102-6113. PubMed ID: 28008149
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
[TBL] [Abstract][Full Text] [Related]
4. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
[TBL] [Abstract][Full Text] [Related]
5. Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.
Chen D; Wei L; Yu J; Zhang L
Clin Cancer Res; 2014 Jul; 20(13):3472-84. PubMed ID: 24763611
[TBL] [Abstract][Full Text] [Related]
6. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification.
Okamoto W; Okamoto I; Arao T; Kuwata K; Hatashita E; Yamaguchi H; Sakai K; Yanagihara K; Nishio K; Nakagawa K
Mol Cancer Ther; 2012 Jul; 11(7):1557-64. PubMed ID: 22729845
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinase inhibition induces PUMA via NF-κB to kill colon cancer cells.
Sun J; Knickelbein K; He K; Chen D; Dudgeon C; Shu Y; Yu J; Zhang L
Mol Cancer Ther; 2014 May; 13(5):1298-308. PubMed ID: 24563542
[TBL] [Abstract][Full Text] [Related]
8. PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.
Sun Q; Ming L; Thomas SM; Wang Y; Chen ZG; Ferris RL; Grandis JR; Zhang L; Yu J
Oncogene; 2009 Jun; 28(24):2348-57. PubMed ID: 19421143
[TBL] [Abstract][Full Text] [Related]
9. Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway.
Yang S; Zhang X; Qu H; Qu B; Yin X; Zhao H
Cancer Gene Ther; 2020 May; 27(5):368-377. PubMed ID: 31182761
[TBL] [Abstract][Full Text] [Related]
10. PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01.
Dudgeon C; Wang P; Sun X; Peng R; Sun Q; Yu J; Zhang L
Mol Cancer Ther; 2010 Nov; 9(11):2893-902. PubMed ID: 20978166
[TBL] [Abstract][Full Text] [Related]
11. Hsp90 inhibitors promote p53-dependent apoptosis through PUMA and Bax.
He K; Zheng X; Zhang L; Yu J
Mol Cancer Ther; 2013 Nov; 12(11):2559-68. PubMed ID: 23966620
[TBL] [Abstract][Full Text] [Related]
12. The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
Sun J; Sun Q; Brown MF; Dudgeon C; Chandler J; Xu X; Shu Y; Zhang L; Yu J
PLoS One; 2012; 7(8):e43158. PubMed ID: 22912816
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
14. Crizotinib overcomes hepatocyte growth factor-mediated resistance to gefitinib in EGFR-mutant non-small-cell lung cancer cells.
Chen X; Zhou JY; Zhao J; Chen JJ; Ma SN; Zhou JY
Anticancer Drugs; 2013 Nov; 24(10):1039-46. PubMed ID: 23962905
[TBL] [Abstract][Full Text] [Related]
15. The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.
Wang X; Li M; Wang J; Yeung CM; Zhang H; Kung HF; Jiang B; Lin MC
Biochem Pharmacol; 2006 May; 71(11):1540-50. PubMed ID: 16595125
[TBL] [Abstract][Full Text] [Related]
16. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer.
Yan J; Yang S; Tian H; Zhang Y; Zhao H
Cell Death Dis; 2020 Nov; 11(11):943. PubMed ID: 33139695
[TBL] [Abstract][Full Text] [Related]
17. ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK.
Sun Y; Nowak KA; Zaorsky NG; Winchester CL; Dalal K; Giacalone NJ; Liu N; Werner-Wasik M; Wasik MA; Dicker AP; Lu B
Mol Cancer Ther; 2013 May; 12(5):696-704. PubMed ID: 23443800
[TBL] [Abstract][Full Text] [Related]
18. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.
Liu Q; Mier JW; Panka DJ
Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745
[TBL] [Abstract][Full Text] [Related]
19. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis.
Ramírez-Labrada A; López-Royuela N; Jarauta V; Galán-Malo P; Azaceta G; Palomera L; Pardo J; Anel A; Marzo I; Naval J
Clin Transl Oncol; 2015 Feb; 17(2):121-32. PubMed ID: 25037851
[TBL] [Abstract][Full Text] [Related]
20. Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis.
Sun L; Huang Y; Liu Y; Zhao Y; He X; Zhang L; Wang F; Zhang Y
Cell Death Dis; 2018 Sep; 9(9):911. PubMed ID: 30185800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]